Skip to main content

Day: November 19, 2019

Husky Energy to Announce 2020 Capital Plan and Production Outlook

CALGARY, Alberta, Nov. 19, 2019 (GLOBE NEWSWIRE) — Husky Energy (TSX:HSE) will release its planned 2020 capital expenditure and production guidance before markets open on Monday, December 2, 2019. A conference call will be held the same day beginning at 8 a.m. Mountain Time (10 a.m. Eastern Time).CEO Rob Peabody and members of the senior management team will participate in the call.                                                 Investor and Media Inquiries:         Leo Villegas, Senior Manager, Investor Relations403-513-7817Kim Guttormson, Media & Issues Specialist403-298-7088

Continue reading

Navios Maritime Holdings Inc. Announces the Date for the Release of Third Quarter 2019 Results, Conference Call and Webcast

Conference Call & Webcast: Monday, November 25, 2019 at 8:30 am ETMONACO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings”) (NYSE:NM) announced today that it will host a conference call Monday, November 25, 2019 at 8:30 am ET, at which time Navios Holdings’ senior management will provide highlights and commentary on earnings results for the third quarter and nine months ended September 30, 2019. The Company will report results for the third quarter and nine months ended September 30, 2019, prior to the conference call.A supplemental slide presentation will be available on the Navios Holdings website at www.navios.com under the “Investors” section by 8:00 am ET on the day of the call.Conference Call details:Call Date/Time: Monday, November 25, 2019 at 8:30 am ETCall...

Continue reading

MPHASE REPORTS RECORD QUARTERLY REVENUE DURING FIRST FISCAL QUARTER

Gaithersburg, MD, Nov. 19, 2019 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTC: XDSL) (“mPhase” or the “Company”) today reported financial results for its first fiscal 2020 quarter ended September 30, 2019. In conjunction with this release, the Company is also providing additional details on its strategy for the remainder of fiscal 2020. For Q1/2020, management is noting the following items of importance:Revenue set an all-time record of $7.6 million, compared to zero revenue reported in Q1/2019;Sequential Q1/2020 quarter-over-quarter revenue increased 203% compared to $2.5 million in revenue reported in the prior quarter (Q4/2019);Gross profit was 24.6%, as expected for the current revenue mix;The Company incurred $1.2 million of software development costs from the use of consultant developers as demand for the Company’s technology...

Continue reading

SUMR Brands Announces CEO Transition

WOONSOCKET, R.I., Nov. 19, 2019 (GLOBE NEWSWIRE) — SUMR Brands (“SUMR Brands” or the “Company”) (NASDAQ: SUMR), a global leader in premium infant and juvenile products, today announced that Mark Messner will be stepping down as the Company’s Chief Executive Officer to pursue other opportunities and spend time with his family. The Board of Directors has begun a search for an interim CEO to replace Mr. Messner, who will remain in his role to assist in the transition until December 13, 2019 or such earlier date that his successor is appointed.About SUMR Brands, Inc.Based in Woonsocket, Rhode Island, the Company is a global leader of premium juvenile brands driven by a commitment to people, products, and purpose. The Company is made up of a diverse group of experts with a passion to make family life better by...

Continue reading

Venus Concept Receives Health Canada Authorization to Market Venus Bliss in Canada

TORONTO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market Venus Bliss™, a medical aesthetic platform that offers a comprehensive solution to fat reduction and cellulite reduction, with two technologies in one platform. It is intended for use in non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, and is also indicated for use in temporary skin tightening, circumferential reduction, and cellulite reduction.Venus Bliss is a non-invasive medical aesthetic device that offers a comprehensive solution with two technologies in one system. The 1064 nm diode laser applicators are used to treat...

Continue reading

Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results

SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2019.“Vir Biotechnology was founded to leverage advances in immunology, creating new ways of combatting serious infectious diseases on a global scale,” said George Scangos, Ph.D., Chief Executive Officer of Vir. “In three years, we have assembled four technology platforms and built a broad pipeline targeting some of the world’s largest infectious diseases, including hepatitis B virus, influenza A, human immunodeficiency virus, and tuberculosis. Execution by our team has enabled us to...

Continue reading

ESCO Announces Fiscal 2019 Results

St. Louis, Nov. 19, 2019 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter (Q4 2019) and fiscal year ended September 30, 2019 (2019).On November 18, 2019, the Company announced the divestiture of its Technical Packaging segment under a separate release, where it expects to receive $187 million in gross cash proceeds and finalize the transaction as soon as customary regulatory items are completed.The financial results presented include certain non-GAAP financial measures such as EBIT, EBITDA, Adjusted EBITDA and Adjusted EPS, as defined within the “Non-GAAP Financial Measures” described below. Any non-GAAP financial measures presented are reconciled to their respective GAAP equivalents.Management believes these non-GAAP financial measures are useful...

Continue reading

Endonovo Therapeutics Reports Third Quarter 2019 Results

Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), announced today its financial results for the quarter ended September 30, 2019.Key Financial Highlights:Revenues for the three months ended September 30, 2019 increased 153% to $54,039, as compared to $21,306 for the same period last year.Revenues for the nine months ended September 30, 2019 increased 293% to $161,720, as compared to $41,132 for the same period last year.Key Business Highlights:Endonovo is now selling SofPulse®, its noninvasive Electroceutical® therapeutic device, in seven hospitals, eleven surgery centers and fourteen other medical facilities.Endonovo is in all 50 states covered by either sales representatives and/or master principals.Endonovo has 113 sales representatives...

Continue reading

Vornado Continues to Lead in Sustainability: Awarded NAREIT’s Leader in the Light Award for the Tenth Consecutive Year

NEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) announced today that for the tenth consecutive year it has been awarded the National Association of Real Estate Investment Trust’s (NAREIT) 2019 Leader in the Light Award for sustainability for diversified REITs.  Contributing to the success in earning the Leader in the Light Award was Vornado’s high standing in the Global Real Estate Sustainability Benchmark (GRESB).  In 2019 Vornado ranked number 4 among all responding listed companies in the United States, and placed in the top 6% of GRESB respondents worldwide.Vornado continues to lead the industry in sustainability owning and operating more than 26 million square feet of LEED certified buildings, with over 22 million square feet at LEED Gold.  More information can be found in Vornado’s 2018 Environmental,...

Continue reading

Ferroglobe PLC Schedules Third Quarter 2019 Earnings Investor Call for December 3, 2019

LONDON, Nov. 19, 2019 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ:GSM) announced today that it will discuss third quarter 2019 financial results and Ferroglobe’s business outlook on Tuesday, December 3, 2019. Ferroglobe invites all interested persons to participate on its conference call at 9:00 AM, Eastern Time. The dial-in number for the call for participants in the United States is 877-293-5491 (conference ID 5768864). International callers should dial +1 914-495-8526 (conference ID 5768864). Please dial in at least five minutes prior to the call to register. The call may also be accessed via an audio webcast available at https://edge.media-server.com/mmc/p/8nkuu92xDate: December 3, 2019Time: 9:00 AM ESTListen via Internet: https://edge.media-server.com/mmc/p/8nkuu92xUnited States: 877-293-5491 (conference ID 5768864)International:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.